Mansour; Tarek Suhayl

Patent Applications and Registrations

Patent applications and USPTO patent grants for Mansour; Tarek Suhayl.The latest application filed is for "compounds containing benzo[d][1,3]oxathiole, benzo[d][1,3]oxathiole 3-oxide or benzo[d][1,3]oxathiole 3,3-dioxide and methods/uses thereof as agonists of g protein-coupled receptor 119".

Company Profile

2.22.41

Mansour; Tarek Suhayl - New City NY
Mansour; Tarek Suhayl - New York NY

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Compounds Containing Benzo[d][1,3]oxathiole, Benzo[d][1,3]oxathiole 3-oxide Or Benzo[d][1,3]oxathiole 3,3-dioxide And Methods/uses Thereof As Agonists Of G Protein-coupled Receptor 119 App 20210300907 - Mansour; Tarek Suhayl ; et al.	2021-09-30
Compounds containing benzo[d][1,3]oxathiole, benzo[d][1,3]oxathiole 3-oxide or benzo[d][1,3]oxathiole 3,3-dioxide and methods/uses thereof as agonists of g protein-coupled receptor 119 Grant 10,906,894 - Mansour , et al. February 2, 2	2021-02-02
Compounds Containing Benzo[d][1,3]oxathiole, Benzo[d][1,3]oxathiole 3-oxide Or Benzo[d][1,3]oxathiole 3,3-dioxide And Methods/us App 20190292173 - Mansour; Tarek Suhayl ; et al.	2019-09-26
1,2-dithiolane and dithiol compounds useful in treating mutant EGFR-mediated diseases and conditions Grant 10,351,540 - Mansour July 16, 2	2019-07-16
1,2-dithiolane and dithiol compounds useful in treating mutant EGFR-mediated diseases and conditions Grant 10,246,444 - Mansour	2019-04-02
1,2-dithiolane And Dithiol Compounds Useful In Treating Mutant Egfr-mediated Diseases And Conditions App 20180208584 - MANSOUR; Tarek Suhayl	2018-07-26
1,2-dithiolane And Dithiol Compounds Useful In Treating Mutant Egfr-mediated Diseases And Conditions App 20180208564 - MANSOUR; Tarek Suhayl	2018-07-26
Triazine compounds as PI3 kinase and mTOR inhibitors Grant 10,022,381 - Venkatesan , et al. July 17, 2	2018-07-17
Triazine Compounds As Pi3 Kinase And Mtor Inhibitors App 20170224696 - VENKATESAN; Aranapakam Mudumbai ; et al.	2017-08-10
Triazine Compounds As Pi3 Kinase And Mtor Inhibitors App 20170119778 - VENKATESAN; Aranapakam Mudumbai ; et al.	2017-05-04
Asymmetric Syntheses For Spiro-oxindole Compounds Useful As Therapeutic Agents App 20170066777 - Sun; Shaoyi ; et al.	2017-03-09
Asymmetric syntheses for spiro-oxindole compounds useful as therapeutic agents Grant 9,487,535 - Sun , et al. November 8, 2	2016-11-08
Triazine compounds as PI3 kinase and MTOR inhibitors Grant 9,174,963 - Venkatesan , et al. November 3, 2	2015-11-03
Triazine Compounds As Pi3 Kinase And Mtor Inhibitors App 20150011752 - VENKATESAN; Aranapakam Mudumbai ; et al.	2015-01-08
Triazine compounds as PI3 kinase and mTOR inhibitors Grant 8,859,542 - Venkatesan , et al. October 14, 2	2014-10-14
Triazine Compounds As Pi3 Kinase And Mtor Inhibitors App 20140248239 - VENKATESAN; Aranapakam Mudumbai ; et al.	2014-09-04
Triazine compounds as P13 kinase and MTOR inhibitors Grant 8,748,421 - Venkatesan , et al. June 10, 2	2014-06-10
Triazine Compounds As Pi3 Kinase And Mtor Inhibitors App 20130315865 - VENKATESAN; Aranapakam Mudumbai ; et al.	2013-11-28
Triazine compounds as PI3 kinase and mTOR inhibitors Grant 8,575,159 - Venkatesan , et al. November 5, 2	2013-11-05
Asymmetric Syntheses For Spiro-oxindole Compounds Useful As Therapeutic Agents App 20130274483 - Sun; Shaoyi ; et al.	2013-10-17
Triazine compounds as PI3 kinase and mTOR inhibitors Grant 8,445,486 - Venkatesan , et al. May 21, 2	2013-05-21
Triazine Compounds As Pi3 Kinase And Mtor Inhibitors App 20130109670 - VENKATESAN; Aranapakam Mudumbai ; et al.	2013-05-02
Triazine Compounds As Pi3 Kinase And Mtor Inhibitors App 20130005723 - Venkatesan; Aranapakam Mudumbai ; et al.	2013-01-03
Triazine compounds as PI3 kinase and mTOR inhibitors Grant 8,217,036 - Venkatesan , et al. July 10, 2	2012-07-10
9-aminocarbonylsubstituted derivatives of glycylcyclines Grant 8,101,590 - Sum , et al. January 24, 2	2012-01-24
Triazine Compounds As Pi3 Kinase And Mtor Inhibitors App 20110312955 - VENKATESAN; Aranapakam Mudumbai ; et al.	2011-12-22
Triazine compounds as PI3 kinase and mTOR inhibitors Grant 8,039,469 - Venkatesan , et al. October 18, 2	2011-10-18
Glutamate aggrecanase inhibitors Grant 7,998,965 - Sum , et al. August 16, 2	2011-08-16
Indole Based Receptor Crth2 Antagonists App 20110105509 - Kaila; Neelu ; et al.	2011-05-05
Bicyclic 6-alkylidene-penems as .beta.-lactamase inhibitors Grant 7,812,014 - Venkatesan , et al. October 12, 2	2010-10-12
Tricyclic 6-alkylidene-penems as .beta.-lactamase inhibitors Grant 7,691,842 - Venkatesan , et al. April 6, 2	2010-04-06
4-aryloxyquinolin-2(1h)-ones As Mtor Kinase And Pi3 Kinase Inhibitors, For Use As Anti-cancer Agents App 20100068204 - Tsou; Hwei-Ru ; et al.	2010-03-18
3-substituted-1h-indole, 3-substituted-1h-pyrrolo[2,3-b]pyridine And 3-substituted-1h-pyrrolo[3,2-b]pyridine Compounds, Their Use As Mtor Kinase And Pi3 Kinase Inhibitors, And Their Syntheses App 20100061982 - Ayral-Kaloustian; Semiramis ; et al.	2010-03-11
Bicyclic and Tricyclic Substituted 6-Methylidene Carbapenems as Broad Spectrum Beta-Lactamase Inhibitors App 20100063023 - Mansour; Tarek Suhayl ; et al.	2010-03-11
11-Beta HSD1 Inhibitors App 20100029648 - Xiang; Jason Shaoyun ; et al.	2010-02-04
Glutamate Aggrecanase Inhibitors App 20100010012 - Sum; Phaik-Eng ; et al.	2010-01-14
(2-aryl-7h-pyrrolo[2,3-d]pyrimidin-4-yl)morpholine Compounds, Their Use As Mtor Kinase And Pi3 Kinase Inhibitors, And Their Syntheses App 20100003250 - Chen; Zecheng ; et al.	2010-01-07
11-beta HSD1 inhibitors Grant 7,632,838 - Xiang , et al. December 15, 2	2009-12-15
Triazine Compounds As Pi3 Kinase And Mtor Inhibitors App 20090304692 - Venkatesan; Aranapakam Mudumbai ; et al.	2009-12-10
Heteroaryl Ethers And Processes For Their Preparation App 20090291971 - Mansour; Tarek Suhayl ; et al.	2009-11-26
Triazine Compounds As Pi3 Kinase And Mtor Inhibitors App 20090291079 - Venkatesan; Aranapakam Mudumbai ; et al.	2009-11-26
2-Aryl- and 2-Heteroarylthiazolyl Compounds, Methods for Their Preparation and Use Thereof App 20090270363 - Zhang; Nan ; et al.	2009-10-29
[a]-FUSED INDOLE COMPOUNDS, THEIR USE AS mTOR KINASE AND PI3 KINASE INHIBITORS, AND THEIR SYNTHESES App 20090192147 - Ayral-Kaloustian; Semiramis ; et al.	2009-07-30
Glutamate aggrecanase inhibitors Grant 7,553,873 - Sum , et al. June 30, 2	2009-06-30
Processes For Preparing Bicyclic Oxazine Carboxaldehyde and Beta-Lactamase Inhibitors App 20090018332 - Kremer; Kenneth Alfred Martin ; et al.	2009-01-15
Tricyclic 6-Alkylidene-Penems as Beta-Lactamase Inhibitors App 20080318921 - Venkatesan; Aranapakam Mudumbai ; et al.	2008-12-25
Bicyclic 6-Alkylidene-Penems as Beta-Lactamase Inhibitors App 20080312203 - Venkatesan; Aranapakam Mudumbai ; et al.	2008-12-18
4-substituted or unsubtituted-7-hydro-1,4-thiazepine-7-[bicyclic or tricyclic heteroaryl] substituted-3,6-dicarboxylic acid derivatives as beta-lactamase inhibitors App 20070232582 - Mansour; Tarek Suhayl ; et al.	2007-10-04
11-Beta HSD 1 inhibitors App 20070219198 - Xiang; Jason Shaoyun ; et al.	2007-09-20
4-substituted or unsubstituted-7-hydro-1,4-thiazepine-7-[bicyclic or tricyclic heteroaryl] substituted-3,6-dicarboxylic acid derivatives as .beta.-lactamase inhibitors Grant 7,229,983 - Mansour , et al. June 12, 2	2007-06-12
9-Aminocarbonylsubstituted derivatives of glycylcyclines App 20070049564 - Sum; Phaik-Eng ; et al.	2007-03-01
Bicyclic 6-alkylidene-penems as class-D beta-lactamases inhibitors App 20060276445 - Mansour; Tarek Suhayl ; et al.	2006-12-07
Tricyclic 6-alkylidene-penems as class-D beta-lactamases inhibitors App 20060276446 - Mansour; Tarek Suhayl ; et al.	2006-12-07
Bicyclic 6-alkylidene-penems as .beta.-lactamase inhibitors Grant 7,112,582 - Venkatesan , et al. September 26, 2	2006-09-26
Tricyclic 6-alkylidene-penems as beta-lactamase inhibitors App 20060074064 - Venkatesan; Aranapakam Mudumbai ; et al.	2006-04-06
Tricyclic 6-alkylidene-penems as .beta.-lactamase inhibitors Grant 7,018,997 - Venkatesan , et al. March 28, 2	2006-03-28
11-Beta HSD1 inhibitors App 20060025445 - Xiang; Jason Shaoyun ; et al.	2006-02-02
4-Substituted or unsubstituted-7-hydro-1,4-thiazepine-7-[bicyclic or tricyclic heteroaryl] substituted-3,6-dicarboxylic acid derivatives as beta-lactamase inhibitors App 20040214812 - Mansour, Tarek Suhayl ; et al.	2004-10-28
Process for preparing 6-alkylidene penem derivatives App 20040132708 - Abe, Takao ; et al.	2004-07-08
Bicyclic 5-alkylidene-penems as beta lactamases inhibitors App 20040077622 - Venkatesan, Aranapakam Mudumbai ; et al.	2004-04-22
Process for preparing 6-alkylidene penem derivatives App 20040053913 - Abe, Takao ; et al.	2004-03-18
Tricyclic 6-alkylidene-penems as beta-lactamase inhibitors App 20040043978 - Venkatesan, Aranapakam Mudumbai ; et al.	2004-03-04

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.